Seer, Inc. (SEER)

Market Cap	105.51M -6.6%
Revenue (ttm)	15.17M -0.9%
Net Income	-70.49M
EPS	-1.25
Shares Out	56.42M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	215,624
Open	1.790
Previous Close	1.790
Day's Range	1.790 - 1.870
52-Week Range	1.650 - 2.410
Beta	1.64
Analysts	Strong Buy
Price Target	4.00 (+113.9%)
Earnings Date	May 13, 2026

About SEER

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers ...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Dec 4, 2020
• Employees: 124
• Stock Exchange: NASDAQ
• Ticker Symbol: SEER
• Website: https://seer.bio

Financial Performance

In 2025, Seer, Inc.'s revenue was $16.58 million, an increase of 16.99% compared to the previous year's $14.17 million. Losses were -$73.60 million, -15.01% less than in 2024.

Analyst Summary

According to 2 analysts, the average rating for SEER stock is "Strong Buy." The 12-month stock price target is $4.0, which is an increase of 113.90% from the latest price.

Price Target

$4.0

(113.90% upside)

Analyst Consensus: Strong Buy